Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HLA-DQB2 |
| Upstream (Parents) |
|---|
| (<<) TXNDC3 → HLA-DQB2 |
| (<<) RGS5 → HLA-DQB2 |
| (<<) P2RY14 → HLA-DQB2 |
| (<<) CD37 → HLA-DQB2 |
| (<<) LOC100133811///LOC100133661///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 → HLA-DQB2 |
| (<<) LSP1 → HLA-DQB2 |
| (<<) CD74 → HLA-DQB2 |
| Downstream (Children) |
|---|
| HLA-DQB2 → AMELX (>>) |
| HLA-DQB2 → HLA-DQB1 (>>) |
| HLA-DQB2 → S100A7 (>>) |
| HLA-DQB2 → TXNDC3 (>>) |
| HLA-DQB2 → DEFB4A (>>) |
| HLA-DQB2 → RAPGEF1 (>>) |
| HLA-DQB2 → SPNS1///LAT (>>) |
| HLA-DQB2 → DIMT1L (>>) |
| HLA-DQB2 → INSL4 (>>) |
